News
Article Open Access in Pharmacological Reports 2/2020
We strongly recommend reading an interesting article titled "Adverse effects of interactions between antipsychotics and medications used in the treatment of cardiovascular disorders" published in Open
Access (Pharmacological Reports 2/2020).
Free access to all Covid-19 related research results
On March 13, the United States Office for Science and Technology Policy
(OSTP) initiated a campaign which is supported by the National Science
Advisors of 12 other countries. The request is to deposit all
published articles (Version of Record) reporting on research results
related to Covid-19 in the repositories of PubMed Central (PMC) and the
World Health Organization (WHO). The campaign is asking to let researchers have free access, full reuse rights, and text and data mining (TDM) rights.
New date of the 4th CEBC congress
Dear Chairpersons, Dear Participants of the 4th Central European Biomedical Congress, The Organizing Committee of 4th CEBC regretfully inform you about cancellation of this congress planned for 19-22 May 2020. This decision has been reached as an act of precaution against development of coronavirus (COVID-19). The health and safety of all of you constitute our top priority. The new date of the 4th CEBC congress is announced for 4-8 June 2021.
Article Open Access in Pharmacological Reports 1/2020
We strongly recommend reading an interesting article titled "New
therapeutic strategies in nonalcoholic fatty liver disease: a focus on
promising drugs for nonalcoholic steatohepatitis" published in Open
Access (Pharmacological Reports 1/2020).
